Boston Healthcare to expand pricing, economics and reimbursement consulting svcs

By Admin
Boston Healthcare is expanding its health economics, pricing, and reimbursement consulting services with the forming of the advisory practice in Asia...

Boston Healthcare is expanding its health economics, pricing, and reimbursement consulting services with the forming of the advisory practice in Asia.

This enhanced presence in Asia Pacific region enables Boston Healthcare to continue to effectively meet the reimbursement and market access needs of the pharmaceutical, medical device and diagnostic companies globally.

The Asia practice will be headed by Betty Su, who will become the managing director for Boston Healthcare Associates International HongKong Limited, leading a team of consultants supporting clients in Hong Kong, China and other Asia-Pacific markets. Ms. Su has done his specialization in market access and regulatory strategy in China.

She also advises on drug, device and diagnostics companies on commercialization and business development opportunities. She also advises on biopharmaceutical, medical devices, imaging and diagnostic companies in areas of pricing, and reimbursement, sales and marketing, marketing development and growth strategy. 

Before her consulting role, Ms. Su held several positions at AstraZeneca in China in marketing, government affairs and corporate communications.  

Joseph V. Ferrara, President of Boston Healthcare said, “With our expanded presence in Asia, and the addition of Betty Su to our leadership team, Boston Healthcare continues to grow and enhance our strategic advisory to innovative companies around the globe.” Mr. Ferrara also said, “Hong Kong and China are rapidly growing pharmaceutical and medical device markets, as well as emerging leaders in health care technology innovation. The expansion of our practice in Asia provides our clients with strong support in reimbursement and market access in this vital region."

Share
Share

Featured Articles

SpaceX Starlink Launch Boost for Indonesia Healthcare

As SpaceX CEO Elon Musk helps launch new satellite in Indonesia, we look at how the Starlink programme is improving healthcare provision in remote areas

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Johnson & Johnson takes collaborative approach to tackling the problem of carbon emissions in the global healthcare supply chain

Walgreens to Sell Over-the-Counter Opioid Overdose Drug

As Walgreens launches an own-brand opioid overdose reversal drug, we take a look at the role of naloxone in combatting decades of US opioid deaths

McKinsey Health Institute: Focus on Health Insights Body

Digital Healthcare

AstraZeneca & Celonis Map out Digital Transformation

Technology & AI

Google DeepMind's AlphaFold 3 'is Drug Discovery Boost'

Technology & AI